Capital raised by NGM Bio
1 Form D filing · first filed Jul 2024 · South San Francisco, CA
Tim Kutzkey is on file as Director at NGM Bio in South San Francisco, CA. NGM Bio has 1 Form D filing on record, $142.0M raised in total.
An investigational monoclonal antibody antagonist of GFRAL, the receptor for GDF15, designed to block GDF15 signaling in brainstem cells that trigger nausea, vomiting and appetite suppression.
